The Food and Drug Administration, or FDA on Thursday announced that it had approved Gilead Sciences’ remdesivir as a coronavirus treatment. Following the announcement, shares of Gilead we...
Shares of cancer drugmaker Immunomedics doubled after Gilead Sciences announced on Sunday that it will acquire the company for $21 billion, or $88 per share in cash.In pre-market trading on Monday, Im...
When the COVID-19 pandemic recently broke out in the US, a few pharmaceuticals took it upon themselves to develop a vaccine or treatment for the coronavirus, and Gilead Sciences was one of the fore-ru...